I don't think we're making that assertion or that claim. We don't have a policy responsibility to encourage innovation. We're an economic regulatory body that ensures that prices of patented medicines aren't excessive. There are a lot of other things going on within government, both federally and provincially. Quebec in particular has an organization, a public-private partnership, called Catalis. They're doing amazing work to try to bring in more clinical trials in that province.
I don't think it's the purview of PMPRB to ensure that its guidelines, regulations and regime in its totality encourage R and D. It would be nice if it did, but we don't have that mandate.